James Marshall
Partner
James has experience in Intellectual Property, with a focus on patent litigation in the telecommunications, life sciences and pharmaceutical fields. His expertise includes FRAND disputes, patent and IP licensing, misuse of confidential information and IP licence disputes.
James's experience
-
Represented Ericsson in multiple SEP/FRAND disputes since 2011, including against Apple (in 2015 and in 2022), Samsung (2021), Lenovo/Motorola (2023-2025), and TCL/TCT (2013-2015).
- United Kingdom
- Telecommunications
-
Advised OPPO, a global smartphone manufacturer, in UK FRAND litigation brought by Panasonic over 4G patents. The case involved parallel proceedings in Germany, China, and the UPC. Settled shortly before the UK trial in October 2024, the matter included claims on patent infringement and FRAND licence scope.
- United Kingdom
- Telecommunications
-
Acted for OPPO in SEP/FRAND litigation involving InterDigital, Mitsubishi, and Sisvel from 2019 to 2024.
- United Kingdom
- Telecommunications
-
Represented implementers in SEP/FRAND disputes against Philips (2016 - 2020) and France Brevets (2015).
- United Kingdom
- Technology, Science & Industry
-
Advised on confidential disputes governed by English law arising from partnering and collaboration agreements in the life sciences and pharmaceutical sectors (2013–2019).
- United Kingdom
- Life Sciences & Healthcare
-
Represented Generics (UK) in key pharmaceutical cases from 2002 to 2015, Cephalon v. Orchid (modafinil), litigation up to the House of Lords concerning escitalopram, and a series of trials over alendronate.
- United Kingdom
- Life Sciences & Healthcare
-
Involved in patent disputes concerning plant protection products from 2011 to 2015.
- United Kingdom
- Life Sciences & Healthcare
-
Acted for Teva in various pharmaceutical patent litigation cases from 2002 to 2015.
- United Kingdom
- Life Sciences & Healthcare
-
Acted for Merial in revocation proceedings brought by Omnipharm concerning the veterinary product FRONTLINE from 2009 to 2013.
- United Kingdom
- Life Sciences & Healthcare
-
Represented Lilly ICOS in patent revocation proceedings against Pfizer and represented Eli Lilly in a dispute with Novo Nordisk involving licence rectification proceedings, from 1998 to 2002.
- United Kingdom
- Life Sciences & Healthcare
Credentials
-
2023Pinsent Masons, Partner
-
1997Taylor Wessing, Partner
-
1987Lovell White Durrant (now Hogan Lovells)
Out-Law / Insight by James Marshall
People who viewed James Marshall also viewed
Show me all
Bill Ryan
Partner
Bill specialises in advising the construction, engineering and energy industry sectors primarily in relation to contentious matters. His recent experience includes co-managing large teams in arbitration proceedings arising from LNG and processing plant projects in Queensland and Western Australia.
Barry McCaig
Partner, Head of Office, Glasgow
Barry is Head of the Glasgow office and of the Corporate practice group in Scotland.
Bryn Reynolds
Partner
Bryn is a chartered accountant and chartered tax advisor who advises large businesses on all indirect tax issues including VAT, IPT and customs duties. He primarily advises large financial institutions and TMT clients including FinTech.
Ben McKinley
Partner
Ben’s expertise is advising and representing employers in all aspects of employment, industrial relations, and safety law. He is highly regarded for his pragmatic and strategic advice, and works closely with clients to build trust and an in-depth understanding of their business.